Key facts
- Notable investors include Hongxin Guotai (Beijing) Investment, JC Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Guangna Anliao Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Guangna Anliao Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guangna Anliao Technology
Manufacturer of medical devices and biomaterials intended for hospitals, research institutions, and medical device distributors seeking next-generation solutions for complex clinical needs. The company is engaged in the research, development, and manufacturing of Class III medical devices based on novel nanomaterials, thereby enabling clients to gain access to safer, more effective treatment options and scalable pilot-stage commercialization services.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Guangna Anliao Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guangna Anliao Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guangna Anliao Technology in its N-PORT filings yet. We sweep new filings monthly.